Skip to main content
ATOMO DIAGNOSTICS LIMITED logo

ATOMO DIAGNOSTICS LIMITED — Investor Relations & Filings

Ticker · AT1 ISIN · AU0000080327 ASX Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2023-01-26 Interim / Quarterly Rep…
Country AU Australia
Listing ASX AT1

About ATOMO DIAGNOSTICS LIMITED

https://www.atomodiagnostics.com/

Atomo Diagnostics Limited specializes in the design and manufacture of integrated rapid diagnostic test (RDT) platforms. The company focuses on improving the usability and reliability of point-of-care testing through its proprietary AtomoRapid technology. This platform integrates essential components, such as a safety lancet and a calibrated blood collection system, into a single, user-friendly device. Key applications include HIV screening, COVID-19 detection, and pregnancy testing. By simplifying the testing procedure and reducing the risk of user error, the company provides solutions for both professional clinical environments and consumer self-testing markets. Its products are designed to deliver laboratory-grade accuracy in decentralized settings, supporting global health initiatives and individual health management.

Recent filings

Filing Released Lang Actions
Quarterly Activity Report - 31 December 2022 6 pages 199.3KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activity Report Q2 FY23' and provides detailed financial and operational information for the quarter ended 31 December 2022. It includes unaudited revenue figures, cash receipts, sales volumes, agreements, and strategic priorities. The length of the document (over 10,000 characters) and the presence of substantive financial data and analysis indicate it is a comprehensive quarterly report rather than a brief announcement or certification. The document is not an earnings release (which would be shorter and focused on key highlights), nor is it an annual report or audit report. It fits the definition of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and contains actual financial statements and substantive analysis. Therefore, the appropriate classification is IR with high confidence. Q2 2023
2023-01-26 English
Agreement for Rapid Pregnancy Tests Signed with NG Biotech 3 pages 197.7KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated January 18, 2023, describing a new commercialisation agreement between Atomo Diagnostics and NG Biotech for distribution and manufacture of a blood-based rapid pregnancy test. It details the terms of the agreement, market territories, regulatory plans, and strategic importance. The content is a press release announcing a business partnership and commercial strategy, not a financial report, earnings release, or regulatory filing. It does not contain financial statements, voting results, or management changes. The document is a corporate announcement about a commercial agreement and market expansion. Therefore, the most appropriate classification is Capital/Financing Update (CAP), as it relates to company fundraising, financing activities, or capital structure changes, specifically commercial agreements impacting company operations and market presence.
2023-01-17 English
Appointment of Independent Non-Executive Director 1
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 15 November 2022 about the appointment of an independent Non-Executive Director, Dr Cheri Walker, to the Board of Atomo Diagnostics Limited. It details her background, experience, and the company's statement welcoming her. There is no financial data, no mention of a report or filing, and the content focuses solely on management/board changes. This fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing, but a direct announcement of a board appointment.
2022-11-14 English
Initial Director's Interest Notice - Dr Walker 2 pages 264.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the appointment of a director and their relevant interests in securities, with no securities held. This is a report of personal share transactions or interests by a company director. The document length is short and focused solely on director interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2022-11-14 English
Investor Webinar and Presentation 17 pages 1.6MB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 28 October 2022, titled 'Atomo Investor Webinar Presentation'. It announces a webinar event where the CEO and CFO will discuss key highlights from the September Quarter and provide an overview of the company. The content includes detailed presentation slides with financial highlights, product information, and strategic positioning. The document is about 15,000 characters long and contains detailed presentation material intended for investors. It is not a transcript of a call, nor is it a full annual or quarterly report with comprehensive financial statements. It is a presentation prepared for investors focusing on financials, strategy, and market position. Therefore, the document fits the definition of an Investor Presentation (IP).
2022-10-27 English
2022 Annual General Meeting - Chairman's Address 3 pages 170.7KB
AGM Information Classification · 95% confidence The document is titled '2022 Annual General Meeting – Chairman’s Address' and is an ASX announcement dated 27 October 2022. It contains the Chairman's speech delivered at the Annual General Meeting (AGM) of Atomo Diagnostics Limited. The content includes a welcome, discussion of the financial year, company strategy, market positioning, and board composition, which are typical elements of a Chairman's address at an AGM. There is no detailed financial data or comprehensive report content, but rather a presentation or speech given at the AGM. Therefore, this document fits the category of AGM Information (AGM-R). The document length is 7246 characters, which is consistent with a detailed AGM address rather than a brief announcement or a full annual report.
2022-10-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.